The legacy of Viagra and the medicinal industry presents a intricate picture for prospective investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, creating significant profits and defining the current pharmaceutical landscape. However, intellectual property expiration and the emergence of generic versions